Lucy Liu, Ph.D. ’17, is a principal at Longwood Fund, where she is involved in creating and supporting portfolio companies. At Longwood, Dr. Liu has played key roles in building ImmuneID, Tome Biosciences and Carbon Biosciences.
Prior to Longwood Fund, Dr. Lui was a Damon Runyon Cancer Research Foundation Postdoctoral fellow at Harvard Medical School with Norbert Perrimon, Ph.D., where she studied communication between the adipose tissue and the brain. She also was a fellow at 5AM Ventures, assisting in diligence and company creation. Dr. Liu completed her graduate studies in neuroscience with Hugo Bellen, D.V.M., Ph.D., at Baylor College of Medicine, where she characterized the mechanism of lipid droplets in the degenerating brain, which resulted in first-author publications in Cell and Cell Metabolism. She has received numerous international awards for her scientific accomplishments, including the Larry Sandler Memorial Award from the Genetics Society of America and the Harold M. Weintraub Graduate Student Award from the Fred Hutch Cancer Center, formerly known as the Fred Hutch Cancer Research Institute. Dr. Liu received her Bachelor of Science in biology from The University of North Carolina at Chapel Hill, from which she graduated with honors.
